Observational Study
Copyright ©The Author(s) 2022.
World J Methodol. Sep 20, 2022; 12(5): 414-427
Published online Sep 20, 2022. doi: 10.5662/wjm.v12.i5.414
Table 3 Subgroup analysis among migraineurs based on awareness of their disease

Migraine awareness


Migraine aware (n = 21)
Not aware (n = 27)
P
GenderFemales: 13 (61.9%); Males: 8 (38.1%)Females: 15 (55.5%); Males: 12 (45.5%)0.65
Diagnostic criteriaRemember: 12 (57.1%); don’t remember: 9 (42.9%)Remember: 13 (48%); don’t remember: 14 (52%)0.53
Know prophylaxis indicationsKnow indications: 11 (52.4%); do not know about either prophylaxis or its indications: 10 (47.6%)Know indications: 10 (37%); do not know about either prophylaxis or its indications: 17 (63%)0.44
Aura essential for diagnosis?No: 13 (61.9%); yes or not sure: 8No: 13 (48.1%); yes or not sure: 14 (51.9%)0.34
ConsultedNeurologist: 6 (28.6%); Any other physician: 11 (52.4%); Didn't consult: 4 (19%)1Neurologist: 2 (7.4%); Any other physician: 10 (37%); Didn’t consult: 151 (55.6%)0.02; OR: 9.6 (95%CI: 1.5-96)
Monthly attack cutoff for prophylaxisCorrectly identified: 5 (23.8%); Couldn't identify: 16 (76.2%)Correctly identified: 11 (40.7%); Couldn't identify: 16 (59.2%)0.22
Know duration of prophylaxisCorrectly identified: 6 (28.5%); Couldn't identify:15 (71.4%)Correctly identified: =7 (33.3%); Couldn’t identify: 20 (66.7%)0.83
Respondent’s frequency of attacks (per month)None: 1 (4.8%); ≤ 1: 8 (38.1%); 2: 2 (9.5%); 3: 3 (14.3%); ≥ 4: 7 (33.3%)None: 3 (11.1%); ≤ 1: 8 (29.6%); 2: 7 (25.9%); 3: 3 (11.1%); ≥ 4: 6 (22.2%)0.5
Average no of triggers recognizedMedian: 3, IQR: 3Median: 4, IQR: 30.32
Average no of indications recognizedMedian: 1, IQR: 1Median: 2, IQR: 10.17